The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia

Leukemia. 2010 Apr;24(4):890-1. doi: 10.1038/leu.2009.297. Epub 2010 Jan 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Alemtuzumab
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / administration & dosage*
  • Antibodies, Neoplasm / pharmacology
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacology
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Injections, Intravenous
  • Injections, Subcutaneous
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab